Cargando…

Pre-radiotherapy neutrophil-to-lymphocyte ratio as an independent prognostic factor in patients with locally advanced hepatocellular carcinoma treated with radiotherapy

We aimed to investigate the pre-radiotherapy neutrophil-to-lymphocyte ratio (prNLR) as a prognostic factor in patients with locally advanced hepatocellular carcinoma (HCC) treated with radiotherapy (RT), and to determine the optimal cut-off value for prNLR. We retrospectively evaluated 56 patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Son, Seok Hyun, Park, Eun Young, Park, Hee Hyun, Kay, Chul Seung, Jang, Hong Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370014/ https://www.ncbi.nlm.nih.gov/pubmed/28199977 http://dx.doi.org/10.18632/oncotarget.15209

Ejemplares similares

Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy
por: Sung, SooYoon, et al.
Publicado: (2017)

Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma
por: Oh, Byong Sun, et al.
Publicado: (2013)

Prognostic Value of the Neutrophil-to-Lymphocyte Ratio before and after Radiotherapy for Anaplastic Thyroid Carcinoma
por: Park, Jiyun, et al.
Publicado: (2021)

Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2014)

Radiotherapy-Induced High Neutrophil-to-Lymphocyte Ratio is a Negative Prognostic Factor in Patients with Breast Cancer
por: Yoon, Chang Ik, et al.
Publicado: (2020)

Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy
por: Ng, Sweet Ping, et al.
Publicado: (2020)

Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
por: Kim, Myungsoo, et al.
Publicado: (2014)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Preoperative Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in Uterine Sarcoma
por: Jeong, Min Jin, et al.
Publicado: (2020)

The Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Head and Neck Cancer Patients Treated with Radiotherapy
por: Cho, Yeona, et al.
Publicado: (2018)

Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy
por: Song, Jin Ho, et al.
Publicado: (2015)

Association of the neutrophil-to-lymphocyte ratio and CA 125 with the endometriosis score
por: Kim, Seul Ki, et al.
Publicado: (2014)

The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis
por: Jeong, Yujin, et al.
Publicado: (2021)

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio for Repeat Cerclage in Women with Prolapsed Membranes
por: Song, Ji Eun, et al.
Publicado: (2018)

A Customized Bolus Produced Using a 3-Dimensional Printer for Radiotherapy
por: Kim, Shin-Wook, et al.
Publicado: (2014)

Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results
por: Bae, Sun Hyun, et al.
Publicado: (2017)

The prognostic value of the ratio of neutrophils to lymphocytes before and after intensity modulated radiotherapy for patients with nasopharyngeal carcinoma
por: Liu, Jing, et al.
Publicado: (2020)

Neutrophil-lymphocyte ratio as a prognostic factor for stereotactic body radiotherapy treatment of metastatic liver tumors
por: Xie, Xuyun, et al.
Publicado: (2020)

Meta-Analysis on the Neutrophil-Lymphocyte Ratio in Rectal Cancer Treated With Preoperative Chemoradiotherapy: Prognostic Value of Pre- and Post-Chemoradiotherapy Neutrophil-Lymphocyte Ratio
por: Lee, Soo Jin, et al.
Publicado: (2022)

Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer
por: Kim, Jae Hyun, et al.
Publicado: (2017)

The prognostic value of red cell distribution width (RDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) in radiotherapy for oropharyngeal cancer
por: Staniewska, Emilia, et al.
Publicado: (2021)

A meta-analysis of the impact of neutrophil-to-lymphocyte ratio on treatment outcomes after radiotherapy for solid tumors
por: Choi, Noorie, et al.
Publicado: (2019)

Neutrophil-to-lymphocyte ratio is an independent predictor for neurological disability in patients with idiopathic transverse myelitis
por: Min, Je Hong, et al.
Publicado: (2023)

Time-Sequencing of the Neutrophil-to-Lymphocyte Ratio to Predict Prognosis of Triple-Negative Breast Cancer
por: Kim, Joo-Heung, et al.
Publicado: (2021)

Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer
por: Panje, Cédric, et al.
Publicado: (2017)

Determination of the α/β ratio for the normal liver on the basis of radiation-induced hepatic toxicities in patients with hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2013)

Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
por: Hsiang, Chih-Weim, et al.
Publicado: (2021)

Predictive significance of lymphocyte level and neutrophil‐to‐lymphocyte ratio values during radiotherapy in cervical cancer treatment
por: Zhao, Mengli, et al.
Publicado: (2023)

Prognostic role of the neutrophil-to-lymphocyte ratio in patients with primary central nervous system lymphoma
por: Jung, Jongheon, et al.
Publicado: (2017)

Prognostic Significance of the Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Neuroendocrine Carcinoma
por: Kim, Hyeon-Jong, et al.
Publicado: (2022)

Impact of adaptive intensity-modulated radiotherapy on the neutrophil-to-lymphocyte ratio in patients with nasopharyngeal carcinoma
por: Han, Ning, et al.
Publicado: (2019)

Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer
por: Koh, C-H, et al.
Publicado: (2015)

The Current Evidence of Intensity-Modulated Radiotherapy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Jang, Won Il, et al.
Publicado: (2023)

Neutrophil-to-Lymphocyte Ratio as a Factor Predicting Radiotherapy Induced Oral Mucositis in Head Neck Cancer Patients Treated with Radiotherapy
por: Homa-Mlak, Iwona, et al.
Publicado: (2021)

Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma
por: Najjar, Marc, et al.
Publicado: (2018)

Pretreatment Neutrophil–Lymphocyte Ratio: An Independent Predictor of Survival in Patients With Hepatocellular Carcinoma
por: Gao, Fangyuan, et al.
Publicado: (2015)

Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2018)

Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer
por: Yang, Gowoon, et al.
Publicado: (2022)

Prognostic value of nodal SUV(max) of (18)F-FDG PET/CT in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Lee, So Jung, et al.
Publicado: (2017)

Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis
por: Xiao, Wei-Kai, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p77r5u5rpg2j2cu780fiuie7i3